Related Experiment Videos
Report from the In Vitro Micronucleus Assay Working Group
M Kirsch-Volders1, T Sofuni, M Aardema
1Laboratorium voor Cellulaire Genetica, Vrije Universiteit Brussels, Brussels, Belgium.
Environmental and Molecular Mutagenesis
|March 29, 2000
Summary
Guidelines for the in vitro micronucleus test were developed at a workshop, focusing on cell choice, slide preparation, and analysis. Further studies are needed for a harmonized protocol, especially regarding Cytochalasin B use.
Area of Science:
- Genotoxicity testing
- In vitro toxicology
- Cellular assays
Background:
- The in vitro micronucleus test is a key assay for genotoxicity assessment.
- Existing methodologies and data were reviewed to identify areas for improvement and standardization.
Framework:
- Guidelines were developed for cell selection, emphasizing justification based on doubling time, spontaneous micronuclei frequency, and genetic background.
- Recommendations for slide preparation include using fixation methods that preserve cellular integrity and employing fluorescent DNA-specific dyes for enhanced micronuclei detection.
- Criteria for micronuclei analysis were established, including size relative to the nucleus and clear distinguishability, with specific considerations for binucleated cells and apoptosis.
Implementation:
- Cytotoxicity assessment methods were discussed, with a majority recommendation for the highest concentration to induce at least 50% cytotoxicity.
- The use of Cytochalasin B remains debated; it is recommended for human lymphocytes but considered optional for cell lines pending further research.
- A minimum of three concentrations should be scored, and while definitive treatment/harvest times are not yet established, principles of short and long treatments with recovery periods are suggested.
Implications:
- The workshop established consensus on critical aspects of the in vitro micronucleus test protocol.
- These guidelines aim to improve the consistency and reliability of genotoxicity testing.
- Further validation studies are necessary to achieve a fully harmonized international protocol, particularly concerning the role of Cytochalasin B.